High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression
Advanced Science · 2024
DOI: 10.1002/advs.202310204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Yao-An Yu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan. Hauptthemen laut MEDLINE: Killer Cells, Natural, T-Lymphocytes, Superantigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Confocal Microscopy Core, DNA Sequencing Core, Inflammation Core Facility.
Abstract (Originalsprache)
The development of immune cell engagers (ICEs) can be limited by logistical and functional restrictions associated with fusion protein designs, thus limiting immune cell recruitment to solid tumors. Herein, a high affinity superantigen‐based multivalent ICE is developed for simultaneous activation and recruitment of NK and T cells for tumor treatment. Yeast library‐based directed evolution is adopted to identify superantigen variants possessing enhanced binding affinity to immunoreceptors expressed on human T cells and NK cells. High‐affinity superantigens exhibiting improved immune‐stimulatory activities are then incorporated into a superantigen‐based tri‐functional yeast‐display‐enhanced multivalent immune cell engager (STYMIE), which is functionalized with a nanobody, a Neo‐2/15 cytokine, and an Fc domain for tumor targeting, immune stimulation, and prolonged circulation, respectively. Intravenous administration of STYMIE enhances NK and T cell recruitment into solid tumors, leading to enhanced inhibition in multiple tumor models. The study offers design principles for multifunctional ICEs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Academia Sinica, Taipei, 11529, Taiwan.
- Doctoral Degree Program of Translational Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, 112, Taiwan.
- Department of Chemistry, National Taiwan University, Taipei, 10617, Taiwan.
- Biomedical Translation Research Center, Academia Sinica, Taipei, 11529, Taiwan.
ORCID-Profile: Che-Ming Jack Hu
Förderung
- Confocal Microscopy Core
- DNA Sequencing Core
- Inflammation Core Facility
- Institute of Biomedical Sciences
- National Science and Technology Council
Zitieren
APA
Yu, Y. A., Lien, W. J., Lin, W. C., Pan, Y. C., Huang, S. W., Mou, C. Y., Hu, C. J., & Mou, K. Y. (2024). High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression. Advanced Science. https://doi.org/10.1002/advs.202310204
Vancouver
Yu YA, Lien WJ, Lin WC, Pan YC, Huang SW, Mou CY, et al. High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression. Advanced Science. 2024. doi:10.1002/advs.202310204
BibTeX
@article{Yu2024,
author = {Yu, Yao-An and Lien, Wan-Ju and Lin, Wen-Ching and Pan, Yi-Chung and Huang, Sin-Wei and Mou, Chung-Yuan and Hu, Che-Ming Jack and Mou, Kurt Yun},
title = {High‐Affinity Superantigen‐Based Trifunctional Immune Cell Engager Synergizes NK and T Cell Activation for Tumor Suppression},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202310204}
}
EUVIMED